Price T Rowe Associates Inc Enochian Biosciences Inc Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 15,945 shares of ENOB stock, worth $73,347. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,945Holding current value
$73,347% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ENOB
# of Institutions
42Shares Held
14MCall Options Held
33.7KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA5.64MShares$26 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.73MShares$7.95 Million0.0% of portfolio
-
State Street Corp Boston, MA1.28MShares$5.87 Million0.0% of portfolio
-
Morgan Stanley New York, NY454KShares$2.09 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...